DE69100436D1 - Kalzitonin enthaltende emulsion zur nasalen verabreichung. - Google Patents

Kalzitonin enthaltende emulsion zur nasalen verabreichung.

Info

Publication number
DE69100436D1
DE69100436D1 DE91402231T DE69100436T DE69100436D1 DE 69100436 D1 DE69100436 D1 DE 69100436D1 DE 91402231 T DE91402231 T DE 91402231T DE 69100436 T DE69100436 T DE 69100436T DE 69100436 D1 DE69100436 D1 DE 69100436D1
Authority
DE
Germany
Prior art keywords
nasal administration
calcitonine
containing emulsion
calcitonin
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE91402231T
Other languages
English (en)
Other versions
DE69100436T2 (de
Inventor
Nakayuki Yamamoto
Michihiko Sugimoto
Hideo Sakakibara
Masaru Saita
Yuji Shimozono
Takafumi Manako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Asahi Kasei Pharma Corp
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69100436D1 publication Critical patent/DE69100436D1/de
Application granted granted Critical
Publication of DE69100436T2 publication Critical patent/DE69100436T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
DE91402231T 1990-08-16 1991-08-12 Kalzitonin enthaltende Emulsion zur nasalen Verabreichung. Expired - Fee Related DE69100436T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2215044A JPH078806B2 (ja) 1990-08-16 1990-08-16 カルシトニン類含有経鼻投与用乳剤

Publications (2)

Publication Number Publication Date
DE69100436D1 true DE69100436D1 (de) 1993-11-04
DE69100436T2 DE69100436T2 (de) 1994-01-20

Family

ID=16665828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE91402231T Expired - Fee Related DE69100436T2 (de) 1990-08-16 1991-08-12 Kalzitonin enthaltende Emulsion zur nasalen Verabreichung.

Country Status (13)

Country Link
US (1) US5281580A (de)
EP (1) EP0471618B1 (de)
JP (1) JPH078806B2 (de)
KR (1) KR950000770B1 (de)
AT (1) ATE95063T1 (de)
AU (1) AU629758B2 (de)
CA (1) CA2047903C (de)
DE (1) DE69100436T2 (de)
DK (1) DK0471618T3 (de)
ES (1) ES2060329T3 (de)
IE (1) IE65630B1 (de)
NZ (1) NZ239166A (de)
PT (1) PT98692B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
IT1251685B (it) * 1991-10-11 1995-05-19 Isf Spa Composizioni farmaceutiche contenenti una calcitonina
US5948825A (en) * 1993-04-19 1999-09-07 Institute For Advanced Skin Research Inc. Microemulsion preparation containing a slightly absorbable substance
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
WO2008007214A2 (en) * 2006-07-07 2008-01-17 Avestha Gengraine Technologies Pvt. Ltd. Glycyrrhiza glabra plant extracts for treating osteoporosis and the extraction process thereof
CN102727870B (zh) 2006-09-27 2014-04-30 旭化成制药株式会社 鲑降钙素的应用
WO2011062073A1 (ja) 2009-11-18 2011-05-26 旭化成ファーマ株式会社 ヒト変形性膝関節症の予防剤および／または治療剤および／または増悪抑制剤
US20190210394A1 (en) * 2018-01-05 2019-07-11 Beatrice A. Darby Reading staff book system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2212062A (en) * 1938-04-16 1940-08-20 Harry O Duerr Waste destructor and garbage reclamation unit
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4690852A (en) * 1985-06-11 1987-09-01 Paul Gach Foil for stained glass assembly
EP0234745B1 (de) * 1986-01-29 1991-06-12 Dyson Refractories Limited Katalysatoren
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
GB2212062B (en) * 1987-11-13 1991-07-17 Isf Spa Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH0669956B2 (ja) * 1988-09-30 1994-09-07 旭化成工業株式会社 ポリペプタイド類の吸着防止剤

Also Published As

Publication number Publication date
CA2047903C (en) 1995-12-05
PT98692A (pt) 1992-07-31
CA2047903A1 (en) 1992-02-17
PT98692B (pt) 1999-01-29
IE65630B1 (en) 1995-11-01
KR950000770B1 (ko) 1995-02-02
AU8244591A (en) 1992-02-20
ES2060329T3 (es) 1994-11-16
AU629758B2 (en) 1992-10-08
US5281580A (en) 1994-01-25
KR920003991A (ko) 1992-03-27
DK0471618T3 (da) 1993-11-29
ATE95063T1 (de) 1993-10-15
EP0471618B1 (de) 1993-09-29
EP0471618A1 (de) 1992-02-19
NZ239166A (en) 1992-11-25
IE912614A1 (en) 1992-02-26
JPH0499729A (ja) 1992-03-31
JPH078806B2 (ja) 1995-02-01
DE69100436T2 (de) 1994-01-20

Similar Documents

Publication Publication Date Title
DE69100436D1 (de) Kalzitonin enthaltende emulsion zur nasalen verabreichung.
DK0552256T3 (da) Fremgangsmåde til at behandle eller forebygge type 1 diabetes ved peroral indgivelse af insulin
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
DK358384D0 (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
BR9408343A (pt) Derivados 5-(2-imidazolinil amino) benzimidazol sua preparação e seu uso como agonistas alfa-2 adrenoceptor
FI870219A (fi) Hypoglykemiska tiazolidindioner.
MY102565A (en) Novel derivatives of guanine
ZA874812B (en) Drug
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
DE69226370D1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
DE69122364D1 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
DK0490549T3 (da) Stabilisering af calcitonin-holdige farmaceutiske præparater
NO870560L (no) Nytt farmasoeytisk preparat.
ATE284697T1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
KR910004191A (ko) 신질환치료제
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
EA199900226A1 (ru) Фармацевтические композиции для лечения вирусных заболеваний
KR880004810A (ko) 소화성 궤양 치료제
SE8204670L (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
KR900014308A (ko) 비스펜에탄올아민
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
DK0410876T3 (da) Anvendelse af glufosinat eller et salt deraf til fremstilling af insekticide præparater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASAHI KASEI PHARMA CORP., TOKIO/TOKYO, JP

Owner name: HISAMITSU PHARMACEUTICAL CO., INC., TOSU, SAGA, JP

8339 Ceased/non-payment of the annual fee